Back to search results

Belle.ai Skin Image Tool for Dermatologic Disease

This study is testing a tool called Belle.ai, which uses artificial intelligence (AI) to help healthcare providers diagnose skin conditions. If you join, three pictures of your skin condition will be taken using the Belle.ai software. The AI will then suggest possible diagnoses based on these images. The study aims to see how well Belle.ai's diagnoses match those made by experienced dermatologists. To be successful, Belle.ai's top diagnosis needs to agree with the dermatologists' diagnosis over 80% of the time. This study is for people aged 10 and older who visit an Advocate Health dermatology clinic.

Study design
This is an observational study with a planned enrollment of 400 participants. It is not specified if it is randomized or blinded.
What's involved
You will have three images taken of your dermatologic condition within the Belle.ai software during your clinic visit.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint (concordance of diagnoses) is measured at Day 1, suggesting a short follow-up period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07033169

A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis

Recruiting
Not specifiedAges 10+Observational
Wake Forest University Health Sciences
~400 participants
Updated 2025-10-24 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
concordance of Belle.ai diagnoses with physician diagnoses.
Measured over Day 1

Conditions

Dermatologic Disease

Explore related trials

Skin Disorder

Where it's being run

1 sites across 1 states
North Carolina1

Study leadership

  • Lindsay C Strowd, MD · PRINCIPAL_INVESTIGATOR · Wake Forest University Health Sciences

Who to contact

Irma M Richardson, MHA
[email protected]
336-716-2903
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patient must present to an Advocate Health dermatology clinic
Patient must have the ability and willingness to provide informed consent and comply with study procedures and visits
Participant dermatologists must have access to the required technology (e.g., smartphone with internet access) and be capable of using it for the required image capture

Exclusion

Patients who are unable to comply with study procedures due to physical or mental health limitations (as assessed by study coordinator)
Pediatric, adolescent, and teen patients who present with dermatological conditions on their genitalia will not be included in the study (in support of patient privacy concerns).

What this trial measures

  • concordance of Belle.ai diagnoses with physician diagnoses.Day 1

    The study coordinator will review uploaded patient "cases" and assign them for review and adjudication to designated Dermatologic Review Committee (DRC) members within the Belle web portal. The DRC will be comprised of 1-2 Advocate Health board-certified dermatologists from each of the Winston, Charlotte, and Midwest dermatology practices.